Investigational drug · Phase 2
JMT202
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Hypertriglyceridemia.
Phase 2Last checked: Nov 19, 2026Latest source record: Dec 30, 2025 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
2
Any phase or sponsor naming "JMT202"
First trial start
2025
Sep 9, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "JMT202", any sponsor or status.
Conditions studied
As listed on its trial records.
- Hypertriglyceridemia
Approved drugs for the same conditions: High triglycerides · Cardiovascular and metabolic
Largest trials
Live from ClinicalTrials.gov: studies naming "JMT202" as an intervention, largest first.
- A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JMT202Status unknown
Shanghai JMT-Bio Inc.Industry
NCT06564467 · 54 participants (planned) · Start Jul 23, 2024 · Primary completion Jan 10, 2025
Drug: JMT202; Placrbo · For: Healthy Subjects
Sites: Beijin, China
Shanghai JMT-Bio Inc.Industry
NCT07140809 · 48 participants (planned) · Start Sep 9, 2025 · Primary completion Jul 31, 2026
Drug: JMT202 injection · For: Hypertriglyceridemia
Sites: Beijing, China
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Hypertriglyceridemia
- SHR-1918Phase 37 trials
Beijing Suncadia Pharmaceuticals Co., Ltd · Homozygous Familial Hypercholesterolemia, Hyperlipidemia, Hypercholesterolemia
- DR10624Phase 35 trials
Zhejiang Doer Biologics Co., Ltd. · Severe Hypertriglyceridemia, Hypertriglyceridemia, Severe Hypertriglyceridemia (sHTG)
- MAR001Phase 23 trials
Marea Therapeutics · Hypertriglyceridemia
- RBD5044Phase 22 trials
Ribocure Pharmaceuticals AB · Dyslipidemias, Hypertriglyceridemia
- ION775Phase 21 trial
Ionis Pharmaceuticals · Hypertriglyceridemia, Severe Hypertriglyceridemia
- MN-001Phase 21 trial
MediciNova · Diabetes Mellitus, Type 2, Hypertriglyceridemia, Non-Alcoholic Fatty Liver Disease
- RN0361Phase 21 trial
Ikaria Bioscience Pty Ltd · Hypertriglyceridemia, Familial Chylomicronemia Syndrome
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.